Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Cardiac Magnetic Resonance Imaging of Cardiac Amyloidosis.

Chao R, Ivanov A, Efthimiou P.

J Clin Rheumatol. 2018 Feb 22. doi: 10.1097/RHU.0000000000000693. [Epub ahead of print] No abstract available.

PMID:
29708515
2.

Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups.

Feist E, Quartier P, Fautrel B, Schneider R, Sfriso P, Efthimiou P, Cantarini L, Lheritier K, Leon K, Karyekar CS, Speziale A.

Clin Exp Rheumatol. 2018 Jul-Aug;36(4):668-675. Epub 2018 Mar 2.

3.

EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report.

Bottai M, Tjärnlund A, Santoni G, Werth VP, Pilkington C, de Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Danko K, Dimachkie MM, Feldman BM, García-De La Torre I, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinka M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O'Callaghan A, Wook Song Y, Vencovsky J, Ytterberg SR, Miller FW, Rider LG, Lundberg IE; International Myositis Classification Criteria Project consortium, the Euromyositis register and the Juvenile Dermatomyositis Cohort Biomarker Study and Repository (JDRG) (UK and Ireland) .

RMD Open. 2017 Nov 14;3(2):e000507. doi: 10.1136/rmdopen-2017-000507. eCollection 2017.

4.

Tumor necrosis factor-associated periodic syndrome in adults.

Menon SG, Efthimiou P.

Rheumatol Int. 2018 Jan;38(1):3-11. doi: 10.1007/s00296-017-3820-4. Epub 2017 Sep 23. Review.

PMID:
28942479
5.

IgG4-related disease: a complex under-diagnosed clinical entity.

Yadlapati S, Verheyen E, Efthimiou P.

Rheumatol Int. 2018 Feb;38(2):169-177. doi: 10.1007/s00296-017-3765-7. Epub 2017 Jul 5. Review.

PMID:
28681251
6.

Recommendations for optimizing methotrexate treatment for patients with rheumatoid arthritis.

Bello AE, Perkins EL, Jay R, Efthimiou P.

Open Access Rheumatol. 2017 Mar 31;9:67-79. doi: 10.2147/OARRR.S131668. eCollection 2017. Review.

7.

Autoimmune/Inflammatory Arthritis Associated Lymphomas: Who Is at Risk?

Yadlapati S, Efthimiou P.

Biomed Res Int. 2016;2016:8631061. doi: 10.1155/2016/8631061. Epub 2016 Jun 27. Review.

8.

Inadequate response or intolerability to oral methotrexate: Is it optimal to switch to subcutaneous methotrexate prior to considering therapy with biologics?

Yadlapati S, Efthimiou P.

Rheumatol Int. 2016 May;36(5):627-33. doi: 10.1007/s00296-016-3447-x. Epub 2016 Mar 2. Review.

PMID:
26936262
9.

Screening Optimization of Latent Tuberculosis Infection in Rheumatoid Arthritis Patients.

Mehta B, Zapantis E, Petryna O, Efthimiou P.

Arthritis. 2015;2015:569620. doi: 10.1155/2015/569620. Epub 2015 Jul 29.

10.

Impact of IL-1 inhibition on fatigue associated with autoinflammatory syndromes.

Yadlapati S, Efthimiou P.

Mod Rheumatol. 2016;26(1):3-8. doi: 10.3109/14397595.2015.1069459. Epub 2015 Aug 3. Review.

PMID:
26140469
11.

Use of B lymphocyte stimulator inhibitor belimumab may be associated with a decrease in the serum concentration of epidermal growth factor in patients with primary Sjögren's syndrome.

Kadavath S, Bobic S, Efthimiou P.

Clin Rheumatol. 2015 Sep;34(9):1651-2. doi: 10.1007/s10067-015-2872-7. Epub 2015 Feb 5. Review.

PMID:
25652332
12.

Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options.

Kadavath S, Efthimiou P.

Ann Med. 2015 Feb;47(1):6-14. doi: 10.3109/07853890.2014.971052. Epub 2015 Jan 22. Review.

PMID:
25613167
13.

A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult-onset Still's disease: targeting IL-6.

Kadavath S, Zapantis E, Zolty R, Efthimiou P.

Int J Rheum Dis. 2014 Mar;17(3):336-40. doi: 10.1111/1756-185X.12324. Epub 2014 Feb 28. Review.

PMID:
24581387
14.

Life-threatening complications of adult-onset Still's disease.

Efthimiou P, Kadavath S, Mehta B.

Clin Rheumatol. 2014 Mar;33(3):305-14. doi: 10.1007/s10067-014-2487-4. Epub 2014 Jan 17. Review.

PMID:
24435354
15.

Can traumatic injury trigger psoriatic arthritis? A review of the literature.

Hsieh J, Kadavath S, Efthimiou P.

Clin Rheumatol. 2014 May;33(5):601-8. doi: 10.1007/s10067-013-2436-7. Epub 2013 Nov 19. Review.

PMID:
24249146
16.

Adult Onset Still's Disease and Autoinflammation.

Efthimiou P, Moorthy LN, Mavragani CP, Skokos D, Fautrel B.

Int J Inflam. 2012;2012:964751. doi: 10.1155/2012/964751. Epub 2012 Aug 29. No abstract available.

17.

IL-1 Trap rilonacept in refractory adult onset Still's disease.

Petryna O, Cush JJ, Efthimiou P.

Ann Rheum Dis. 2012 Dec;71(12):2056-7. doi: 10.1136/annrheumdis-2012-201409. Epub 2012 Jun 7. No abstract available.

PMID:
22679302
18.

Ferritin in adult-onset still's disease: just a useful innocent bystander?

Mehta B, Efthimiou P.

Int J Inflam. 2012;2012:298405. doi: 10.1155/2012/298405. Epub 2012 Mar 25. Erratum in: Int J Inflam. 2012;2012:254858.

19.

The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease.

Kontzias A, Efthimiou P.

Semin Arthritis Rheum. 2012 Oct;42(2):201-5. doi: 10.1016/j.semarthrit.2012.03.004. Epub 2012 Apr 17.

PMID:
22512815
20.

Radiographic improvement in sarcoid arthropathy after infliximab treatment.

Mehta B, Efthimiou P.

J Rheumatol. 2012 Mar;39(3):664-5. doi: 10.3899/jrheum.111002. No abstract available.

PMID:
22383361

Supplemental Content

Loading ...
Support Center